Matthew E. Gegg
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
GLP-1 and Parkinson's Disease: A Comprehensive Review of Biology, Mechanisms and Efficacy.
Journal: Cells
Published: April 08, 2026
Serum phosphorylated tau 217 in GBA1 variant carriers with and without Parkinson disease.
Journal: Journal of Parkinson's disease
Published: January 22, 2026
Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarker.
Journal: Parkinsonism & related disorders
Published: March 07, 2025
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson's disease.
Journal: The Journal of cell biology
Published: December 16, 2024
The influence of the glymphatic system on α-synuclein propagation: the role of aquaporin-4.
Journal: Brain : a journal of neurology
Published: September 13, 2024
Elevated cholesterol in ATAD3 mutants is a compensatory mechanism that leads to membrane cholesterol aggregation.
Journal: Brain : a journal of neurology
Published: July 20, 2023
α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study.
Journal: Brain communications
Published: April 19, 2023
The importance of being connected: membrane contact sites and Parkinson's disease.
Journal: Neural regeneration research
Published: April 14, 2023
Unexpected phenotypic and molecular changes of combined glucocerebrosidase and acid sphingomyelinase deficiency.
Journal: Disease models & mechanisms
Published: October 23, 2022
Lysosomal-endolysomal dysfunction and neurodegenerative diseases.
Journal: Neurobiology of disease
Published: August 25, 2022
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments.
Journal: Neurobiology of disease
Published: December 05, 2021
Last Updated: 09/26/2026